HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM
Delisted
HTGM was delisted on the 14th of June, 2023.
21 hedge funds and large institutions have $622K invested in HTG Molecular Diagnostics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$102K | |
| 2 | +$102K | |
| 3 | +$61.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$59K |
| 5 |
Citigroup
New York
|
+$17.9K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$563K | |
| 3 | -$462K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$397K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$176K |